The OPTION (Optimal Anti-Tachycardia Therapy in Implantable Cardioverter-Defibrillator Patients Without Pacing Indications) trial sought to compare long-term rates of inappropriate shocks, mortality, and morbidity between dual-chamber and single-chamber settings in implantable cardioverter-defibrillators (ICDs) patients.
However, inappropriate therapies, most commonly caused by supraventricular tachyarrhythmias (SVTs), remain a significant adverse effect of ICD therapy, affecting up to 40% of patients during long-term follow-up (6) (7) (8) (9) (10) . Besides the pain and discomfort caused by inappropriate shocks, they are also associated with anxiety, depression, impaired quality of life, proarrhythmia, low treatment satisfaction, and possibly mortality (11) (12) (13) .
Important efforts have been made in defining optimal programming methods for accurate rhythm detection and minimizing inappropriate ICD interventions. However, so far, there is no consensus on the most appropriate programming methodology (14) (15) (16) (17) . Likewise, the question of whether dualchamber ICD therapy with dual-chamber settings can reduce the risk for inappropriate shocks in comparison with single-chamber therapy with singlechamber settings remains unanswered. Several investigators have reported a trend toward fewer inappropriate shocks with dual-chamber setting (18) , whereas others have reported no differences between the therapies (19) (20) (21) (22) . Moreover, additional factors should be considered when choosing single-versus dual-chamber ICD settings, including the risk for complications (23) , as well as the detrimental effect of unnecessary ventricular pacing (24) . Therefore, the potential superiority of dual-chamber over singlechamber ICD settings in terms of inappropriate shocks can be assessed only in the light of optimal tachyarrhythmia discrimination algorithms combined with optimized bradycardia parameters for minimized ventricular pacing (25) .
The OPTION (Optimal Anti-Tachycardia Therapy in Implantable Cardioverter-Defibrillator Patients Without Pacing Indications) trial was designed to compare long-term outcomes in ICD recipients with dualchamber settings with those in patients with singlechamber settings. All patients received atrial leads and dual-chamber devices, the only difference being the pacing mode setting. The programming in both groups was optimized to minimize ventricular pacing and to reduce inappropriate shocks using discrimination algorithms along with standardized antitachycardia pacing (ATP) therapies.
METHODS
TRIAL DESIGN. The rationale and design of OPTION have been published previously (25) STATISTICAL ANALYSES. As the study had 2 primary endpoints, the significance level for each primary endpoint was set at 0.025. For all other tests, the significance level was set at 0.05. Different prespecified analyses were applied to assess the primary endpoint: Kaplan-Meier analysis for the time of first occurrence of inappropriate shock with a logrank test to validate the difference and a Student t test for equivalence testing after normal approximation to assess whether the difference in the occurrence of specific cardiovascular events or death between randomization groups was less than 17%.
Time-to-event and survival curves were estimated by using the Kaplan-Meier approach and are displayed as descriptive graph (11) .
For other dichotomous variables, the chi-square test and the Fisher exact test were used as appropriate. Continuous variable were compared using the Student t test when normal distribution was confirmed; otherwise the Wilcoxon rank test was used. Table 2 ). The pre-specified equivalence analysis with a margin of 17% confirmed the equivalence of dual-chamber setting therapy to single-chamber setting therapy Figure 2B illustrates the occurrence of the events over time. Table 3) . The difference in rates of patients with shocks was driven by a lower frequency of patients with SVT-triggered inappropriate shocks in the dual-chamber setting group (1.3%) compared with the single-chamber setting group (7.6%) (p ¼ 0.001). The rates of patients with only appropriate shocks were similar in both groups (11.7% and 12.6% in the dual-chamber setting and singlechamber setting groups, respectively).
Inappropriate shocks were delivered throughout the 27-month follow-up period at a rate of 7.3%, with no clustering at any specific time point. A total of 6 patients in the dual-chamber setting group (2.6%) and 17 patients in the single-chamber setting group (7.6%) received at least 1 inappropriate shock over 12 months (p ¼ 0.015), as did 10 patients in the dual-chamber setting group (4.3%) and 23 patients in the singlechamber setting group (10.3%) at the end of the 27-month period (p ¼ 0.015) ( Table 3) . The number of patients needed to treat to prevent 1 patient from experiencing an inappropriate shock was 17.
The reasons for inappropriate shocks in the 2 treatment groups included SVTs, responsible for 73.6% of the events, and lead failure or oversensing in 25.5% of the events ( Table 4 ). In patients in the dual-chamber setting arm, lead failure or oversensing was the major reason for inappropriate shocks (70.8%). In patients in the single-chamber setting arm, SVTs triggered 86.6% of all inappropriate Table 2 .
Remarkably, ventricular pacing did not differ significantly between the groups, with a median of 0% in both groups (p ¼ 0.635) and means of 3.9 AE 13.8% in the dual-chamber setting group and 2.4 AE 8.6% in the single-chamber setting group. Atrial pacing in the dual-chamber setting group was on average 26.7 AE 26.3% (median 17.2%).
SYSTEM-RELATED COMPLICATIONS. In the total study population, 6 patients (1.3%) had atrial lead complications, including dislodgment, perforation, and loss of capture ( Table 5) . Twenty-one patients chamber ICDs, which may be less than with conventional single-chamber ICDs (17, 18) . However, the presumed superiority of dual-chamber ICD has never been shown in prospective, randomized trials for inappropriate shocks on per patient analysis (19) (20) (21) (22) . The lack of statistical significance in these studies may be attributed to inadequate sample sizes of early studies, study design, devices and algorithms used, and device programming (single-zone vs. multiple-zone programming). The results of our trial add an important piece of evidence for the reduction of inappropriate shocks with dual-chamber ICDs (2.6% vs. 7.6% at 1 year, p ¼ 0.015; 4.3% vs.
10.3% at study end, p ¼ 0.012). Values are n (%). *Chi-square test. †Lead failure, myopotential, oversensing, electromagnetic interference.
SVT ¼ supraventricular tachyarrhythmia. Values are n (%). *Chi-square test. †The primary endpoint was tested with an equivalence test. The cumulative number of subitems exceeds the total number of patients with the composite endpoint because multiple criteria of the composite were reached in some patients.
The yearly rate of inappropriate shocks in OPTION (2.6% in the dual-chamber setting group) was of the same magnitude as in the recently conducted MADIT-RIT (Multicenter Automated Defibrillation TrialReduction in Inappropriate Therapy) trial (31) and lower than in several earlier large-scale trials, in which rates of 11% to 13% were reported (12) (13) (14) (15) (16) (17) (18) (19) (20) .
However, recent studies have reported very low overall rates of inappropriate shocks, which may be attributed to shorter follow-up periods, to specific device settings, including a higher tachycardia therapy cutoff rate, and to longer detection times (32) (33) (34) (35) .
Moreover, it should be noted that the high crossover rate observed in our study from dual-chamber to Values are n (%). *Patients in the single-chamber setting group would not have received atrial leads in clinical practice. †6 due to myopotentials, 1 due to connecting problem, 1 due to electromagnetic interference, 1 due to suspected lead failure, and 1 without documented reason. ‡In total, no significant difference was observed between groups (p ¼ 0.052). A sensitivity analysis excluding atrial lead-related complications in the singlechamber setting group confirmed the absence of a significant difference between groups (p ¼ 0.156).
ICD ¼ implantable cardioverter-defibrillator; RV ¼ right ventricular. Values are n (%).
SVT ¼ supraventricular tachyarrhythmia.
monitor zone for the single-chamber group, while ATP with no shock was recommended for the dualchamber group. Such a difference must be considered in addition to the treatment difference that is under randomized investigation.
Given the small number of inappropriate shocks in the dual-chamber setting group, further subgroup analysis with respect to patients who may benefit most from dual-chamber implantation was not possible.
The crossover rate was higher than in some other studies. However, it is not assumed that this has contributed to the positive finding of the trial, because the vast majority of patients switched to the dual-chamber setting group. This has rather diluted the magnitude of the difference between the groups in the intention-to-treat analysis.
The OPTION trial analyzed a specific setting of algorithms enabled by Sorin devices, so the results may not be transferable to dual-chamber ICDs from other manufacturers, which warrants further investigation.
CONCLUSIONS
The OPTION trial showed that therapy with dualchamber setting discrimination combined with algo- kolb@dhm.mhn.de.
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